16-19 October 2018
Novotel Darling Harbour
Australia/Sydney timezone

Interaction of native and modified clupeine with Gram-negative model membranes.

17 Oct 2018, 14:40
20m
Novotel Darling Harbour

Novotel Darling Harbour

100 Murray Street, Pyrmont NSW 2009
Oral Proteins and complexes Mid Afternoon Session

Speakers

Dr Marcia English (Department of Human Nutrition, Saint Francis Xavier University, Antigonish, Nova Scotia)Dr Allan Paulson (Dalhousie University)

Description

Clupeine, a cationic antimicrobial peptide found in the sperm cells of fish, is of interest as a food additive because of its antimicrobial activity against several foodborne pathogens. However, it has previously been shown that non-specific binding of clupeine to anionic molecules reduces its antimicrobial activity. It has also been shown that the overall positive charge of the native peptide can be reduced by blocking 10% of its arginine residues with 1,2-cyclohexanedione (CHD) to form CHD-treated clupeine. CHD-treated clupeine retains antimicrobial activity but it is not known if the modes of interaction against Gram-negative bacteria remain the same as the native peptide. The focus of the present study was to investigate the effect of charge reduction on peptide membrane interactions by comparing the effect of native and CHD-treated clupeine on Escherichia coli (E. coli) model biomembranes.
It was hypothesized that the reduction in charge would result in different interactions with model monolayers composed of E. coli PE, phosphatidylethanolamine, 79 mole%:PG, phosphatidylglycerol, 17 mole%: and CL, cardiolipin, 4 mole%), and model bilayer membranes composed of DPPC,: PE:PG:CL (79:17:4 mole%).
Peptide interaction with the model biomembranes were studied using Neutron Reflectometry (NR) and X-ray reflectometry (XRR) and symmetric bilayers were deposited on silicon blocks applying the Langmuir-Blodgett and Langmuir Schaefer techniques. Some lipid mixing was observed in the inner tail region (~69 ± 0.24% DPPC (1,2-dipalmitoyl (d62)-sn-glycero-3-phosphocholine) and ~24 ± 0.02% PE:PG:CL); and in the outer tail region (~24 ± 0.02% DPPC and ~56 ± 0.01% PE:PG:CL). Native and CHD-treated clupeine were not able to cross the model PE:PG:CL:DPPC bilayer biomembrane, however, CHD-treated clupeine showed increased interactions with the lipid head group. Inspite of the different interactions observed in the model systems, a more comprehensive understanding of the safety and toxicology of both peptides is required before they can be used for food applications.

Primary authors

Dr Marcia English (Department of Human Nutrition, Saint Francis Xavier University, Antigonish, Nova Scotia) Dr Allan Paulson (Dalhousie University) Dr Rebecca Green (School of Pharmacy, University of Reading, Reading UK) Dr Olga Florek (University of Reading) Dr Luke Clifton (ISIS, Science and Technology Facilities Council) Dr Richard Frazier (Department of Food and Nutritional Sciences, University of Reading)

Presentation Materials

There are no materials yet.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×